noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Healthcare

Children's National Medical Center[...]

Think tank improves care for Malawian children with seizures -[...]
Children's National Medical Center[...]

Making pediatric epilepsy surgery more accessible - Children's National
Southern Illinois University System

SIU’s state of the art, $7,2M BioLaunch boosts opportunities in[...]

OSE Immunotherapeutics SA

07/24/2024 | Press release | Distributed by Public on 07/23/2024 23:45

24/07/2024 OSE Immunotherapeutics Announces Positive Efficacy Results for Lusvertikimab in the Phase 2 trial for the treatment of Ulcerative Colitis

Sharing and Personal Tools

Please select the service you want to use: